Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Rolls-Royce Holdings plc    RR.   GB00B63H8491


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Rolls Royce : Apprentice Ben on having an unseen disability

12/03/2020 | 10:21am EST
Thursday, 03 December 2020
Apprentice Ben on having an unseen disability

Ben talks about the challenges and complications of living with ulcerative colitis.

More about:

I was just 21 and half way through my Supply Chain Management apprenticeship in Derby when the irritable bowel disease specialist confirmed I had severe ulcerative colitis in 2019. Ulcerative colitis is a condition which causes inflammation of the colon and the rectum. This leads to bleeding, pain and frequently needing to empty your colon.

Soon after my diagnosis, I was put on a course of steroids, the main effect of these being the embarrassing acne that developed over my face and torso. Understandably, both the colitis and the medication had a great effect on my general confidence and I would easily get very tired.

At this time, I was put on placement in Rolls-Royce turbines in Bristol. Helpfully, I was able to relocate back to Bath where I had moved from and commuted to work by train. If I had breakfast before I left I would need to go to use the toilet as soon as I was on the train that was often packed with others commuting to work. A better approach was to take breakfast with me and not eat until after my team meeting around 9 am. My bag was packed with a change of clothes. Before every meeting I would visit the toilet and it was commonplace for me to want to go again when in the meeting. Concentrating proved difficult for me and my progress suffered.

The steroids did not work and now I am on immunosuppressant drugs which have gradually returned me to 'normal' by June 2020. I was classed as moderately at risk from Covid-19 and told to isolate for 12 weeks from March but these restrictions have eased. This is a condition I will have for life and there will be more flare ups but having endured these last 18 months I think I will be better prepared.

Ulcerative colitis is by its nature a hidden disability. It can be difficult coping with a condition where everything appears 'normal' from the outside however with developments in medication, although not curable, it is much easier to manage and live with.

It is important when dealing with a medical condition, hidden or not, to have a good support network round you. I would like to thank all those who have supported me so far in my apprenticeship over the last three years and am keen for others to better understand these types of conditions.

Read more about our OPEN employee resource group for anyone impacted by a disability.


Rolls-Royce Holdings plc published this content on 03 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 December 2020 15:20:04 UTC

© Publicnow 2020
01/22MARKET CHATTER : Rolls-Royce Hires Consulting Firm to Identify New Chairman
01/21ROLLS ROYCE : Digital culture courses top Rolls-Royce free training as subscribe..
01/21ROLLS-ROYCE : Jefferies reaffirms its Buy rating
01/20ROLLS ROYCE : Electrical team readies for its biggest power...
01/20ROLLS ROYCE : secures research contract with US Navy to develop innovative debri..
01/20MARKET CHATTER : MTU Aero Engines Mulls Bid for Rolls-Royce's Spanish Part Suppl..
01/19ROLLS ROYCE : The long range aircraft making the world a smaller...
01/18ROLLS-ROYCE TO DELIVER THE FIRST 8-C : 45 gas engine series
01/15ROLLS ROYCE : Leading the way in customer training
01/15ROLLS ROYCE : Power Rangers - The long range aircraft making the...
More news
Sales 2020 11 048 M 15 115 M 15 115 M
Net income 2020 -2 879 M -3 939 M -3 939 M
Net Debt 2020 3 659 M 5 007 M 5 007 M
P/E ratio 2020 -1,31x
Yield 2020 -
Capitalization 8 602 M 11 753 M 11 769 M
EV / Sales 2020 1,11x
EV / Sales 2021 1,09x
Nbr of Employees 51 700
Free-Float 99,4%
Duration : Period :
Rolls-Royce Holdings plc Technical Analysis Chart | RR. | GB00B63H8491 | MarketScreener
Technical analysis trends ROLLS-ROYCE HOLDINGS PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 20
Average target price 94,14 GBX
Last Close Price 102,95 GBX
Spread / Highest target 52,5%
Spread / Average Target -8,56%
Spread / Lowest Target -66,6%
EPS Revisions
Managers and Directors
David Warren Arthur East Chief Executive Officer & Director
Ian Edward Lamert Davis Chairman
Stephen Wayne Daintith Chief Financial Officer & Executive Director
Paul Stein Chief Technology Officer
Lewis William Killcross Booth Independent Non-Executive Director
Sector and Competitors